Go Deep
GoodRx Holdings, Inc.
GoodRx Holdings, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 20,377 | 70.1 | 1.85 | 0.83 | 331.98 |
| Oct 2026 | 20,576 | 67.2 | 1.77 | 0.83 | 318.24 |
| Oct 2026 | 20,367 | 67.4 | 1.77 | 0.83 | 319.53 |
| Oct 2026 | 20,140 | 70.4 | 1.85 | 0.83 | 333.75 |
| Oct 2026 | 20,064 | 71.4 | 1.88 | 0.83 | 337.66 |
| Oct 2026 | 19,988 | 72.4 | 1.91 | 0.83 | 341.69 |
GoodRx Holdings, Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 200,411,000.0 | 194,006,000.0 | 194,785,000.0 | 196,028,000.0 |
| Net Profit | 8,536,000.0 | 1,169,000.0 | 5,425,000.0 | 1,119,000.0 |
| EPS | 0.0 | 0.0 | 0.0 | 0.0 |
GoodRx Holdings, Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 796,853,000.0 | 792,324,000.0 | 750,265,000.0 | 766,554,000.0 | — |
| Net Profit | 30,439,000.0 | 16,390,000.0 | -8,868,000.0 | -32,828,000.0 | — |
| EPS | 0.1 | 0.0 | -0.0 | -0.1 | — |
GoodRx Holdings, Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 1,404,058,000.0 | 1,388,067,000.0 | 1,588,800,000.0 | 1,604,631,000.0 | — |
| Total Liabilities | 787,796,000.0 | 663,409,000.0 | 826,842,000.0 | 789,804,000.0 | — |
| Total Equity | 616,262,000.0 | 724,658,000.0 | 761,958,000.0 | 814,827,000.0 | — |
Owes vs Owns
GoodRx Holdings, Inc. owed $0.72 for every $1 it owned in Jun 2026, up from $0.49 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.72× | 0.56× | 0.48× | 0.52× | 0.49× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
GoodRx Holdings, Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 18.6%Receivables 18.2%Fixed assets (tangible) 2.9%Intangible assets 45.1%Other assets 15.1%
How it's funded — Dec 2025
Long-term debt 34.4%Payables 1.4%Other liabilities 20.0%Shareholders' equity 43.9%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 261.8 | 448.3 | 672.3 | 757.2 |
| Receivables | 254.9 | 160.8 | 160.0 | 121.7 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 41.1 | 40.5 | 45.9 | 55.7 |
| Intangible assets | 633.7 | 587.7 | 567.1 | 602.1 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 212.6 | 150.8 | 143.5 | 68.0 |
| Liabilities & equity | ||||
| Short-term debt | 5.0 | 5.0 | 8.8 | 7.0 |
| Long-term debt | 483.3 | 486.7 | 647.7 | 651.8 |
| Payables | 19.4 | 14.1 | 36.3 | 17.7 |
| Other liabilities | 280.1 | 157.6 | 134.1 | 113.3 |
| Shareholders' equity | 616.3 | 724.7 | 762.0 | 814.8 |
| Net tangible assets | -17.4 | 137.0 | 194.9 | 212.8 |
GoodRx Holdings, Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 167,904,000.0 | 183,892,000.0 | 138,292,000.0 | 146,780,000.0 | — |
| Investing Activities | -119,960,000.0 | -70,347,000.0 | -55,766,000.0 | -210,498,000.0 | — |
| Financing Activities | -234,470,000.0 | -337,495,000.0 | -167,395,000.0 | -120,226,000.0 | — |